CDC: Single-use vials are for one patient only
CDC: Single-use vials are for one patient only
Drug shortages and lean economic times might tempt some to scavenge the remnants of doses left in a "single-dose" vial. After a series of hepatitis outbreaks over the last decade, leaders at the Centers for Disease Control and Prevention (CDC) are concerned. The agency recently restated its position on the use of single-dose/single-use vials and seeks "to dispel inaccuracies being disseminated to healthcare providers."
The CDC concedes that shortages of some essential medications might warrant implementation of meticulously applied practice and quality standards to subdivide contents of single-dose/single-use vials, but this process must be done under rigors standards for pharmaceutical compounding of sterile preparations. The CDC statement reads as follows:
The CDC guidelines call for medications labeled as "single dose" or "single use" to be used for only one patient. This practice protects patients from life-threatening infections that occur when medications get contaminated from unsafe use. Concerns have been raised about whether these guidelines and related policies contribute to drug shortages and increased medical costs to healthcare providers. CDC recognizes the problem of drug shortages; however, such shortages are a result of manufacturing, shipping, and other issues unrelated to the above guidelines. CDC's priority is protecting patients from harm. CDC routinely investigates and is apprised of infectious disease outbreaks involving single-dose/single-use vials being used for multiple patients. These outbreaks cause extensive harm to patients, and they are associated with significant healthcare and legal expenses. Therefore, CDC continues to strongly support its current policies regarding single-dose/single-use vials. It is imperative that drug shortages and drug waste concerns are dealt with appropriately and do not lead to unsafe medical practices that impose increased disease risk on patients.
Drug shortages and lean economic times might tempt some to scavenge the remnants of doses left in a "single-dose" vial.Subscribe Now for Access
You have reached your article limit for the month. We hope you found our articles both enjoyable and insightful. For information on new subscriptions, product trials, alternative billing arrangements or group and site discounts please call 800-688-2421. We look forward to having you as a long-term member of the Relias Media community.